InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,978.00
(
-1.19%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.27
(
0.00%
)
Bitcoin
60,475.42
(
0.34%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Inoviorulez

Send PM Follow Ignore
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Inoviorulez

Re: 136 post# 78162

Monday, 06/17/2013 3:42:20 PM

Monday, June 17, 2013 3:42:20 PM

Post# of 158400
There is always that risk in biotech with trials and FDA, everyone investing in biotech stocks knows this. But if you have been investing in biotech for as long as I have the FDA is more lenient on companies that target rare diseases that are orphan drug status.

Many feel there is a good chance for approval for an unmet medical need Aplastic Anemia which has no current therapy! Think about that the people suffering from this disease have no approved treatments from the FDA! Don't you think the FDA will be somewhat lenient?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up